The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003
about
Ethnic disparities in diabetes management and pay-for-performance in the UK: the Wandsworth Prospective Diabetes StudyPredicting mortality in people with type 2 diabetes mellitus after major complications: a study using Swedish National Diabetes Register data.Attainment of Canadian Diabetes Association recommended targets in patients with type 2 diabetes: a study of primary care practices in St John's, Nfld.Familial risks for type 2 diabetes in Sweden.Mortality trends in subjects with and without diabetes during 33 years of follow-upMetabolic syndrome predicts vascular changes in whole body magnetic resonance imaging in patients with long standing diabetes mellitusDiabetic hypertensive control and treatment: a descriptive report from the audit diabetes control and management (adcm) registryHow can insulin initiation delivery in a dual-sector health system be optimised? A qualitative study on healthcare professionals' viewsDifferences in the Cardiometabolic Control in Type 2 Diabetes according to Gender and the Presence of Cardiovascular Disease: Results from the eControl Study.Receipt of care and reduction of lower extremity amputations in a nationally representative sample of U.S. Elderly.Does increased knowledge of risk and complication of smoking on diabetes affect quit rate? Findings from a randomized controlled trial in kerala, IndiaThe quality of primary care in a country with universal health care coveragePlasma Fibrinogen in Type 2 Diabetic Patients with Metabolic Syndrome and its Relation with Ischemic Heart Disease (IHD) and Retinopathy.Clinical usefulness of different lipid measures for prediction of coronary heart disease in type 2 diabetes: a report from the Swedish National Diabetes Register.Risk of cancer following hospitalization for type 2 diabetes.Prevalence of Type 2 diabetic patients within the targets of care guidelines in daily clinical practice: a multi-center study in Brazil.Impact of a pay-for-performance incentive on support for smoking cessation and on smoking prevalence among people with diabetes.Control of glycemia and cardiovascular risk factors in patients with type 2 diabetes in primary care in Catalonia (Spain).Feasibility of using self-reported patient data in a national diabetes register.A follow-up study of the occurrence and consequences of HbA1c measurements in an unselected cohort of non-pharmacologically treated patients with Type 2 diabetesDoes patient education facilitate diabetic patients' possibilities to reach national treatment targets? A national survey in Swedish primary healthcare.Determinants of uncontrolled hypertension in adult type 2 diabetes mellitus: an analysis of the Malaysian diabetes registry 2009.Current status of glucose, blood pressure and lipid management in type 2 diabetes clinic attendees in Isfahan, Iran.Pathogenesis and treatment of diabetic vascular disease - illustrated by two cases.How can we prevent cardiovascular disease in diabetes.Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register.Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes.Lipid lowering treatment patterns and goal attainment in Nordic patients with hyperlipidemia.Defending the con side: obesity paradox does not exist.Achieving HbA1c targets in clinical trials and in the real world: a systematic review and meta-analysis.Country of birth, socioeconomic factors, and risk factor control in patients with type 2 diabetes: a Swedish study from 25 primary health-care centres.Managed care's clinical and economic impact on patients with type II diabetes in France: a controlled population-based study.The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden.Cardiovascular risk factors are not treated to target in hypertensive patients in primary care.Antihypertensive treatment and control in a large primary care population of 21 167 patients.The disparity between long-term survival in patients with and without diabetes following a first myocardial infarction did not change between 1989 and 2006: an analysis of 6,776 patients in the Northern Sweden MONICA Study.Initiation of insulin glargine therapy in type 2 diabetes subjects suboptimally controlled on oral antidiabetic agents: results from the AT.LANTUS trial.Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register.Clinical characteristics of type 2 diabetic patients on basal insulin therapy with adequate fasting glucose control who do not achieve HbA1c targets.Inadequate treatment of dyslipidemia in people with type 2 diabetes: quality assessment of diabetes care in a Danish County.
P2860
Q28757573-4D632646-D38F-4261-95C0-C8C01BF5B589Q30805323-09704797-001B-41D4-B844-B830B5329D78Q33601860-130C71D8-D8B4-4CC5-A3C5-79AD752D6911Q33602186-A8DF1DBA-3276-4DAE-86BD-BC7DB8AFED9AQ33683678-BF59ECFA-22FB-4814-84B5-E29F29A6D40AQ34114369-7345769A-307E-4F28-B5D9-10A2ECBA6186Q34220846-2D751B7A-FFB1-4862-9F21-9EED104C69B1Q34251486-1BD1705B-5D47-4A8B-9D21-CE6F670E2506Q34307460-82982D76-5E8D-49A6-AD05-F7D9A6401652Q34521134-4840207D-AFDD-4EA6-B6E7-BFFC09C73DC4Q35104693-6AE9A96B-7F15-479F-9103-3F6F341B77E6Q35111884-3C92257C-9BC4-43CF-BE53-2FF387555496Q35139555-2E9AFD18-3DD8-43DA-9E2D-3382EA29D007Q35179874-45FFA3EE-0FD1-45CF-95DE-27BF9D7EE7A2Q35584115-DF1D79E7-84F3-4E6C-9F56-DD49536ED44BQ35612795-D9BAE17E-F353-4191-9BDA-597B43D51565Q35812436-CBDB969B-BE33-4C5E-9652-576253AEEC04Q35841178-2ADE71A3-7A8D-42B9-A406-F17172EC18DCQ35868441-1EF439B0-CAC0-4FBD-B302-2F214138FB7EQ36121950-BE40B6AA-BA5C-4B07-94F1-03F11861D176Q36135435-BC836233-48B9-4BCC-8F41-18B5976C63DAQ36209512-95B1DED0-9C67-4D23-BA85-354316C9C4A3Q36232797-AC704CC5-7807-47BE-B6DC-FD9BB611D766Q36623110-3F384393-B29A-4310-93BF-A5B5E588F427Q36889170-3AD65E86-549C-45F7-ABAF-80043DEFB9ABQ36906271-B6300CA9-EB18-45F9-8E4C-3F56CE09E3CEQ36986188-A7D3F6DF-CA07-4FC6-A815-F1FEC05A09BDQ37210033-29B89C38-FCC7-4BFC-AA3F-F86D32790AC5Q37577114-37615723-9C0C-4075-8AD7-77E46D052B83Q38202019-93AFF371-E419-405E-853D-66F05BB8B981Q39784448-EF63D39B-684C-4B1A-9215-90607B8C6481Q40077696-79E564D2-8839-4AD4-B3AE-3217E8A9C1EBQ42623432-6B385AD4-E3FD-4A3B-8BE7-5D3FD38B6754Q43080305-F313A4F4-479F-49AC-BCE3-C306B863E885Q43644632-302BAFC5-A2E8-4E82-88B8-B1A4D23E86DCQ43713404-8593238D-F786-4FFD-A604-6548E873A8CFQ46691040-2B889DA7-5640-4ED6-80BD-C9D8168C8346Q46942501-0585872B-0F58-4A20-A67F-07812F602CCEQ50271509-B7C11855-4A3D-433B-9078-DED8FBE28A72Q50544168-A66695E0-B3B9-4D13-9519-AAE1E3942455
P2860
The gap between guidelines and reality: Type 2 diabetes in a National Diabetes Register 1996-2003
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The gap between guidelines and ...... al Diabetes Register 1996-2003
@ast
The gap between guidelines and ...... al Diabetes Register 1996-2003
@en
The gap between guidelines and ...... al Diabetes Register 1996-2003
@nl
type
label
The gap between guidelines and ...... al Diabetes Register 1996-2003
@ast
The gap between guidelines and ...... al Diabetes Register 1996-2003
@en
The gap between guidelines and ...... al Diabetes Register 1996-2003
@nl
prefLabel
The gap between guidelines and ...... al Diabetes Register 1996-2003
@ast
The gap between guidelines and ...... al Diabetes Register 1996-2003
@en
The gap between guidelines and ...... al Diabetes Register 1996-2003
@nl
P2093
P2860
P1433
P1476
The gap between guidelines and ...... al Diabetes Register 1996-2003
@en
P2093
J Cederholm
S Gudbjörnsdóttir
Steering Committee of the Swedish National Diabetes Register
P2860
P304
P356
10.1111/J.1464-5491.2005.01648.X
P407
P577
2005-10-01T00:00:00Z